Dergiler / Gülhane Tıp Dergisi / 2021 / Cilt: 63 - Sayı: 4

Vimentin and its role as a biomarker in health and disease

Sayfa
232–237
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The present review focuses on the structure, functions, clinical implications and future scope of vimentin in the management of various diseases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Vimentin is an intermediate filament protein responsible for maintaining cellular integrity and resistance to stress.
📊
Temel Bulgular & Veri:It has a widespread distribution in many cells throughout the body where it forms a cytoskeletal framework.
💡
Sonuç & Katkı:The present review focuses on the structure, functions, clinical implications and future scope of vimentin in the management of various diseases.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Vimentin is an intermediate filament protein responsible for maintaining cellular integrity and resistance to stress. It has a widespread distribution in many cells throughout the body where it forms a cytoskeletal framework. Vimentin plays an important role in the regulation of many cellular and tissue functions. It is overexpressed in malignancies, potentially malignant oral disorders and autoimmune conditions like rheumatoid arthritis and Crohn’s disease. It is associated with cell surface binding and replication of viruses such as human immunodeficiency virus (HIV), severe acute respiratory syndrome-related Coronavirus, dengue and encephalitis. In HIV, it is associated with the viral infectivity factor which is associated with HIV replication. It can be used as a biomarker for diagnosis and prognosis and has potential as a therapeutic target in many conditions. The present review focuses on the structure, functions, clinical implications and future scope of vimentin in the management of various diseases.

🔖

Bu Makaleye Atıf Yap

BABU, G. S., HEGDE, S., AJİLA, V., ASAN, M. F., PANDİTA, V. (2022). Vimentin and its role as a biomarker in health and disease. Gülhane Tıp Dergisi, Cilt: 63 - Sayı: 4, 232–237. https://ajindex.com/articles/526788

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Damjanov I. Antibodies to intermediate filaments and histogenesis. Lab Invest. 1982;47:215-217
  2. Ramos I, Stamatakis K, Oeste CL, Pérez-Sala D. Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections. Int J Mol Sci. 2020;21:4675
  3. Buckley IK, Porter KR. Cytoplasmic fibrils in living cultured cells. A light and electron microscope study. Protoplasma. 1967;64:349-380
  4. Franke WW, Schmid E, Osborn M, Weber K. Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Natl Acad Sci U S A. 1978;75:5034-5038
  5. Perreau J, Lilienbaum A, Vasseur M, Paulin D. Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene. 1988;62:7- 16
  6. Parry DA. Hendecad repeat in segment 2A and linker L2 of intermediate filament chains implies the possibility of a right- handed coiled-coil structure. J Struct Biol. 2006;155:370- 374
  7. Herrmann H, Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu Rev Biochem. 2004;73:749-789
  8. Satelli A, Li S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci. 2011;68:3033-3046
  9. Valgeirsdóttir S, Claesson-Welsh L, Bongcam-Rudloff E, Hellman U, Westermark B, Heldin CH. PDGF induces reorganization of vimentin filaments. J Cell Sci. 1998;111:1973-1980
  10. Inagaki M, Gonda Y, Ando S, Kitamura S, Nishi Y, Sato C. Regulation of assembly-disassembly of intermediate filaments in vitro. Cell Struct Funct. 1989;14:279-286
  11. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776- 1784
  12. Kalluri R, Weinberg RA. The basics of epithelial- mesenchymal transition. J Clin Invest. 2009;119:1420- 1428
  13. Ivaska J. Vimentin: Central hub in EMT induction? Small GTPases. 2011;2:51-53
  14. Gilles C, Polette M, Zahm JM, Tournier JM, Volders L, Foidart JM, et al. Vimentin contributes to human mammary epithelial cell migration. J Cell Sci. 1999;112:4615-4625
  15. Mendez MG, Kojima S, Goldman RD. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition. FASEB J. 2010;24:1838-1851
  16. Liao G, Gundersen GG. Kinesin is a candidate for cross- bridging microtubules and intermediate filaments. Selective binding of kinesin to detyrosinated tubulin and vimentin. J Biol Chem. 1